Paula MPH - Novan CEO Pres
Insider
Paula MPH is CEO Pres of Novan Inc
| Age | 58 |
| Phone | 919 485 8080 |
| Web | https://www.novan.com |
Novan Management Efficiency
The company has return on total asset (ROA) of (0.2584) % which means that it has lost $0.2584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.9889) %, meaning that it created substantial loss on money invested by shareholders. Novan's management efficiency ratios could be used to measure how well Novan manages its routine affairs as well as how well it operates its assets and liabilities.Novan Inc currently holds 3.93 M in liabilities with Debt to Equity (D/E) ratio of 4.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novan Inc has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Novan's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Lisa Delfini | Trevi Therapeutics | 55 | |
| Dr DVM | iBio, Common Stock | 55 | |
| CPA CPA | Tonix Pharmaceuticals Holding | 50 | |
| Bobak MD | Tarsus Pharmaceuticals | N/A | |
| Ian MBA | Jaguar Animal Health | 57 | |
| Daniel MD | Tonix Pharmaceuticals Holding | N/A | |
| MBA MPH | Protara Therapeutics | 41 | |
| Nick DeLong | iBio, Common Stock | N/A | |
| MBA MBA | Adial Pharmaceuticals | 47 | |
| Thomas MD | Trevi Therapeutics | 72 | |
| Christopher Galletta | Trevi Therapeutics | 47 | |
| Dr Roberts | Lyra Therapeutics | 56 | |
| Mark Peikin | Adial Pharmaceuticals | N/A | |
| Kristine Rosse | Protara Therapeutics | N/A | |
| DDS MS | Aditxt Inc | 59 | |
| DSc FRCPsych | Adial Pharmaceuticals | 62 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| Catherine Fratila | Adial Pharmaceuticals | N/A | |
| CFA CFA | Travere Therapeutics | 40 | |
| Leonard JD | Tarsus Pharmaceuticals | 48 | |
Management Performance
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 |
Novan Inc Leadership Team
Elected by the shareholders, the Novan's board of directors comprises two types of representatives: Novan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novan. The board's role is to monitor Novan's management team and ensure that shareholders' interests are well served. Novan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paula MPH, CEO Pres | ||
| John Donofrio, COO VP | ||
| Carri Geer, Senior Vice President and CTO | ||
| JD BS, VP RD | ||
| Brian Johnson, Chief Commercial Officer | ||
| Andrew Novak, Vice President Chief Accounting Officer and Principal Accounting Officer | ||
| MBA MD, Chief Officer | ||
| Cole Ikkala, Communications Relations | ||
| John CPA, CFO Sec |
Novan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.59) % | |||
| Current Valuation | 27.74 M | |||
| Shares Outstanding | 28.02 M | |||
| Shares Owned By Insiders | 0.86 % | |||
| Shares Owned By Institutions | 14.93 % | |||
| Number Of Shares Shorted | 462.95 K | |||
| Price To Earning | (1.49) X |
Pair Trading with Novan
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novan will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Accenture Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Accenture Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Accenture Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Accenture plc to buy it.
The correlation of Accenture Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Accenture Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Accenture plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Accenture Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Novan Stock
If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |